This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Effect of anti-VEGF treatment on PED morphology

Effect of anti-VEGF treatment on PED morphology
Reviewed by Jayavani Myneni

1 June 2015 | Jaya Myneni | EYE - Vitreo-Retinal

This retrospective study of 30 eyes assessed the effect of anti-VEGF on morphology of pigment epithelial detachments (PED) secondary to age-related macular degeneration (AMD). Thirty eyes of 28 patients with PED were compared to 30 eyes of 30 patients with AMD without PED component. The subjects in both groups were individually matched for gender, BCVA before treatment with anti-VEGF, follow-up period and age. All patients received ranibizumab monthly for the first three months followed by PRN treatment. Mean follow-up period was 19.8 months. Morphological changes of PED on OCT were qualitatively assessed by three masked investigators. OCT scans of the same orientation were chosen for comparison only if there was agreement among the three investigators. These changes were correlated with improvements in BCVA. Number of injections and BCVA were compared among the two groups. Extent of PED when compared to baseline were graded as unchanged in 36.7%, reduced in 40% and significantly reduced in 23.3% of eyes. No eyes showed an increase in size. No evidence was found that improvements in PED correlate to improvements in BCVA. No RPE tear was observed in this study. The limitations of the study are small size of study groups, retrospective comparison, lack of quantitative analysis of PED volume and grouping of all types of PED without classification. This study provides supporting evidence that anti-VEGF therapy stabilises or improves PED extent in wet AMD. 

The effect of intravitreal anti-VEGF on the pigment epithelial detachment in eyes with the exudative type of age-related macular degeneration.
Kalouda P, Anastasakis A, Tsika C, Tsilimbaris KM.
SEMINARS IN OPHTHALMOLOGY
2015;30(1):6-10.
Share This
CONTRIBUTOR
Jaya Myneni

Royal Liverpool University Hospitals, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency